Skip to main content
Top
Published in: The journal of nutrition, health & aging 6/2016

01-06-2016

Genetic variants of the FADS gene cluster are associated with erythrocyte membrane LC PUFA levels in patients with mild cognitive impairment

Authors: Jan Philipp Schuchardt, T. Köbe, V. Witte, J. Willers, A. Gingrich, V. Tesky, J. Pantel, D. Rujescu, T. Illig, A. Flöel, A. Hahn

Published in: The journal of nutrition, health & aging | Issue 6/2016

Login to get access

Abstract

Background

Long-chain (> 20 C-atoms) polyunsaturated fatty acids (LC PUFAs) of both the omega-6 (n-6) and omega-3 (n-3) series are important for the functional integrity of brain and thereby cognition, memory and mood. Clinical studies observed associations between altered LC PUFA levels and neurodegenerative diseases such as Alzheimer´s disease and its prodromal stage, mild cognitive impairment (MCI).

Methods

The present study examined the LC PUFA status of MCI patients with specific view on the relative LC n-3 PUFA levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in erythrocyte membranes (omega-3 index). 12 single nucleotide polymorphisms (SNPs) of the FADS1, FADS2, and FADS3 gene clusters were genotyped in 111 MCI patients and evaluated associations with PUFA levels in erythrocyte membranes (primary outcome). In addition, the associations between FADS SNPs and LC PUFA levels with serum lipid levels as well as depressive symptoms were examined (secondary outcomes).

Results

Minor allele carrier of rs174546, rs174548 (FADS1), rs3834458, rs1535, rs174574, rs174575, rs174576, and rs174578 (FADS2) showed significant higher n-6 and n-3 precursor PUFA levels (linoleic acid, and alpha-linolenic acid, respectively) and lower arachidonic acid (AA) levels in erythrocyte membranes compared to the major allele carriers. Differences in EPA and DHA levels were not significant. Minor allele carriers of rs174574, rs174576 and rs174578 (FADS2) and rs174455 (FADS3) exhibited significant higher triglyceride levels, whereas minor allele carriers for rs174449 and rs174455 (FADS3) exhibited significant higher total- and LDL-cholesterol levels compared to the more common variant. The mean omega-3 index of the study cohort was 6.19 ± 1.55 %. In more than 85 % of the patients, the omega-3 index was below 8 % and in 23 % below 5 %. Moreover, it was shown that a low DHA status and omega-3 index was associated with depressive symptoms (Beck’s depression-inventory).

Discussion and conclusion

These findings indicate an association between several FADS genotypes for higher n-6 and n-3 precursor PUFA and lower AA levels in erythrocyte membranes in minor compared to major allele carriers. To what extent FADS genotypes and a lower conversion of LA and ALA to biologically important LC PUFAs such as AA, EPA and DHA contributes to cognitive decline should be investigated in further trials. Nevertheless, the omega-3 index in this cohort of MCI patients can be classified as insufficient.
Literature
1.
go back to reference Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ. Epidemiology of dementias and Alzheimer’s disease. Arch Med Res 2012; 43: 600–608.CrossRefPubMed Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ. Epidemiology of dementias and Alzheimer’s disease. Arch Med Res 2012; 43: 600–608.CrossRefPubMed
2.
go back to reference Qiu C, Kivipelto M, Strauss E von. Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 2009; 11: 111–128.PubMedPubMedCentral Qiu C, Kivipelto M, Strauss E von. Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 2009; 11: 111–128.PubMedPubMedCentral
3.
go back to reference Bazinet RP, Layé S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci 2014; 15: 771–785.CrossRefPubMed Bazinet RP, Layé S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci 2014; 15: 771–785.CrossRefPubMed
4.
go back to reference Luchtman DW, Song C. Cognitive enhancement by omega-3 fatty acids from childhood to old age: findings from animal and clinical studies. Neuropharmacol 2013; 64: 550–565.CrossRef Luchtman DW, Song C. Cognitive enhancement by omega-3 fatty acids from childhood to old age: findings from animal and clinical studies. Neuropharmacol 2013; 64: 550–565.CrossRef
5.
go back to reference Janssen, Carola I F, Kiliaan AJ. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration. Prog Lipid Res 2014; 53: 1–17.CrossRefPubMed Janssen, Carola I F, Kiliaan AJ. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration. Prog Lipid Res 2014; 53: 1–17.CrossRefPubMed
6.
go back to reference Dacks PA, Shineman DW, Fillit HM. Current evidence for the clinical use of longchain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer’s disease. J Nutr Health Aging 2013; 17: 240–251.CrossRefPubMed Dacks PA, Shineman DW, Fillit HM. Current evidence for the clinical use of longchain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer’s disease. J Nutr Health Aging 2013; 17: 240–251.CrossRefPubMed
7.
go back to reference Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairment. Lipids 2000; 35: 1305–1312.CrossRefPubMed Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairment. Lipids 2000; 35: 1305–1312.CrossRefPubMed
8.
go back to reference Kyle DJ, Schaefer E, Patton G, Beiser A. Low serum docosahexaenoic acid is a significant risk factor for Alzheimer’s dementia. Lipids 1999; 34 Suppl: S245.CrossRefPubMed Kyle DJ, Schaefer E, Patton G, Beiser A. Low serum docosahexaenoic acid is a significant risk factor for Alzheimer’s dementia. Lipids 1999; 34 Suppl: S245.CrossRefPubMed
9.
go back to reference Milte CM, Sinn N, Street SJ, Buckley JD, Coates AM, Howe PR. Erythrocyte polyunsaturated fatty acid status, memory, cognition and mood in older adults with mild cognitive impairment and healthy controls. Prostaglandins Leukot Essent Fatty Acids 2011; 84: 153–161.CrossRefPubMed Milte CM, Sinn N, Street SJ, Buckley JD, Coates AM, Howe PR. Erythrocyte polyunsaturated fatty acid status, memory, cognition and mood in older adults with mild cognitive impairment and healthy controls. Prostaglandins Leukot Essent Fatty Acids 2011; 84: 153–161.CrossRefPubMed
10.
go back to reference Lee LK, Shahar S, Chin A et al. Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology (Berl) 2013; 225(3): 605–612.CrossRef Lee LK, Shahar S, Chin A et al. Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology (Berl) 2013; 225(3): 605–612.CrossRef
11.
go back to reference Sinn N, Milte CM, Street SJ, Buckley JD, Coates AM, Petkov J et al. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr 2012; 107: 1682–1693.CrossRefPubMed Sinn N, Milte CM, Street SJ, Buckley JD, Coates AM, Petkov J et al. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr 2012; 107: 1682–1693.CrossRefPubMed
12.
go back to reference Vellas B, Carrie I, Gillette-Guyonnet S et al. MAPT study: A multidomain approach for preventing alzheimer’s disease: design and baseline data. J Prev Alz Dis 2014; 1(1): 13–22. Vellas B, Carrie I, Gillette-Guyonnet S et al. MAPT study: A multidomain approach for preventing alzheimer’s disease: design and baseline data. J Prev Alz Dis 2014; 1(1): 13–22.
13.
go back to reference DGE, Deutsche Gesellschaft für Ernährung (2012) 12. Ernährungsbericht DGE, Deutsche Gesellschaft für Ernährung (2012) 12. Ernährungsbericht
14.
go back to reference Tosi F, Sartori F, Guarini P, Olivieri O, Martinelli N. Delta-5 and delta-6 desaturases: crucial enzymes in polyunsaturated fatty acid-related pathways with pleiotropic influences in health and disease. Adv Exp Med Biol 2014; 824: 61–81.CrossRefPubMed Tosi F, Sartori F, Guarini P, Olivieri O, Martinelli N. Delta-5 and delta-6 desaturases: crucial enzymes in polyunsaturated fatty acid-related pathways with pleiotropic influences in health and disease. Adv Exp Med Biol 2014; 824: 61–81.CrossRefPubMed
15.
go back to reference Marquardt A, Stöhr H, White K, Weber BH. cDNA cloning, genomic structure, and chromosomal localization of three members of the human fatty acid desaturase family. Genomics 2000; 66: 175–183.CrossRefPubMed Marquardt A, Stöhr H, White K, Weber BH. cDNA cloning, genomic structure, and chromosomal localization of three members of the human fatty acid desaturase family. Genomics 2000; 66: 175–183.CrossRefPubMed
16.
go back to reference Cho HP, Nakamura M, Clarke SD. Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J Biol Chem 1999; 274: 37335–37339CrossRefPubMed Cho HP, Nakamura M, Clarke SD. Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J Biol Chem 1999; 274: 37335–37339CrossRefPubMed
17.
go back to reference Cho HP, Nakamura MT, Clarke SD. Cloning, expression, and nutritional regulation of the mammalian Delta-6 desaturase. J Biol Chem 1999; 274: 471–477CrossRefPubMed Cho HP, Nakamura MT, Clarke SD. Cloning, expression, and nutritional regulation of the mammalian Delta-6 desaturase. J Biol Chem 1999; 274: 471–477CrossRefPubMed
18.
go back to reference Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, Pramstaller PP et al. ENGAGE Consortium. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2009; 41: 47–55.CrossRefPubMed Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, Pramstaller PP et al. ENGAGE Consortium. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2009; 41: 47–55.CrossRefPubMed
19.
go back to reference Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010; 42: 105–116.CrossRefPubMedPubMedCentral Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010; 42: 105–116.CrossRefPubMedPubMedCentral
20.
go back to reference Lattka E, Illig T, Heinrich J, Koletzko B. FADS gene cluster polymorphisms: important modulators of fatty acid levels and their impact on atopic diseases. J Nutrigenet Nutrigenomics 2009; 2: 119–128.CrossRefPubMed Lattka E, Illig T, Heinrich J, Koletzko B. FADS gene cluster polymorphisms: important modulators of fatty acid levels and their impact on atopic diseases. J Nutrigenet Nutrigenomics 2009; 2: 119–128.CrossRefPubMed
21.
go back to reference Martinelli N, Girelli D, Malerba G, Guarini P, Illig T, Trabetti E et al. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am J Clin Nutr 2008; 88: 941–949.PubMed Martinelli N, Girelli D, Malerba G, Guarini P, Illig T, Trabetti E et al. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am J Clin Nutr 2008; 88: 941–949.PubMed
22.
go back to reference Caspi A, Williams B, Kim-Cohen J, Craig IW, Milne BJ, Poulton R et al. Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. Proc Natl Acad Sci USA 2007; 104: 18860–18865.CrossRefPubMedPubMedCentral Caspi A, Williams B, Kim-Cohen J, Craig IW, Milne BJ, Poulton R et al. Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. Proc Natl Acad Sci USA 2007; 104: 18860–18865.CrossRefPubMedPubMedCentral
23.
go back to reference Brookes KJ, Chen W, Xu X, Taylor E, Asherson P. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol Psychiatry 2006; 60: 1053–1061.CrossRefPubMed Brookes KJ, Chen W, Xu X, Taylor E, Asherson P. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol Psychiatry 2006; 60: 1053–1061.CrossRefPubMed
24.
go back to reference Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 1989; 39: 1159–1165.CrossRefPubMed Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 1989; 39: 1159–1165.CrossRefPubMed
25.
go back to reference Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303–308.CrossRefPubMed Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303–308.CrossRefPubMed
26.
go back to reference Harris WS, von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 2004; 39: 212–220.CrossRefPubMed Harris WS, von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 2004; 39: 212–220.CrossRefPubMed
27.
go back to reference O’Dwyer L, Lamberton F, Matura S. Tanner C, Scheibe M, Miller J et al. Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study. PLoS ONE 2012; 7: e48895.CrossRef O’Dwyer L, Lamberton F, Matura S. Tanner C, Scheibe M, Miller J et al. Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study. PLoS ONE 2012; 7: e48895.CrossRef
28.
go back to reference Malerba G, Schaeffer L, Xumerle L, Klopp N, Trabetti E, Biscuola M et al. SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 2008; 43: 289–299.CrossRefPubMed Malerba G, Schaeffer L, Xumerle L, Klopp N, Trabetti E, Biscuola M et al. SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 2008; 43: 289–299.CrossRefPubMed
29.
go back to reference Schaeffer L, Gohlke H, Müller M, Heid IM, Palmer LJ, Kompauer I et al. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 2006; 15: 1745–1756.CrossRefPubMed Schaeffer L, Gohlke H, Müller M, Heid IM, Palmer LJ, Kompauer I et al. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 2006; 15: 1745–1756.CrossRefPubMed
30.
go back to reference Bokor S, Dumont J, Spinneker A, Gonzalez-Gross M, Nova E, Widhalm K et al. HELENA Study Group. Single nucleotide polymorphisms in the FADS gene cluster are associated with delta-5 and delta-6 desaturase activities estimated by serum fatty acid ratios. J Lipid Res 2010; 51: 2325–2333.CrossRefPubMedPubMedCentral Bokor S, Dumont J, Spinneker A, Gonzalez-Gross M, Nova E, Widhalm K et al. HELENA Study Group. Single nucleotide polymorphisms in the FADS gene cluster are associated with delta-5 and delta-6 desaturase activities estimated by serum fatty acid ratios. J Lipid Res 2010; 51: 2325–2333.CrossRefPubMedPubMedCentral
31.
go back to reference Xie L, Innis SM. Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J. Nutr. 2008; 138: 2222–2228.CrossRefPubMed Xie L, Innis SM. Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J. Nutr. 2008; 138: 2222–2228.CrossRefPubMed
32.
go back to reference Rzehak P, Heinrich J, Klopp N, Schaeffer L, Hoff S, Wolfram G et al. Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes. Br J Nutr 2009; 101: 20–26.CrossRefPubMed Rzehak P, Heinrich J, Klopp N, Schaeffer L, Hoff S, Wolfram G et al. Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes. Br J Nutr 2009; 101: 20–26.CrossRefPubMed
33.
go back to reference Hellstrand S, Sonestedt E, Ericson U, Gullberg B, Wirfält E, Hedblad B et al. Intake levels of dietary long-chain PUFAs modify the association between genetic variation in FADS and LDL-C. J Lipid Res 2012; 53: 1183–1189.CrossRefPubMedPubMedCentral Hellstrand S, Sonestedt E, Ericson U, Gullberg B, Wirfält E, Hedblad B et al. Intake levels of dietary long-chain PUFAs modify the association between genetic variation in FADS and LDL-C. J Lipid Res 2012; 53: 1183–1189.CrossRefPubMedPubMedCentral
34.
go back to reference Cormier H, Rudkowska I, Paradis A, Thifault E, Garneau V, Lemieux S et al. Association between polymorphisms in the fatty acid desaturase gene cluster and the plasma triacylglycerol response to an n-3 PUFA supplementation. Nutrients 2012; 4: 1026–1041.CrossRefPubMedPubMedCentral Cormier H, Rudkowska I, Paradis A, Thifault E, Garneau V, Lemieux S et al. Association between polymorphisms in the fatty acid desaturase gene cluster and the plasma triacylglycerol response to an n-3 PUFA supplementation. Nutrients 2012; 4: 1026–1041.CrossRefPubMedPubMedCentral
35.
go back to reference Pirillo A, Catapano AL. Omega-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia. Atheroscler Suppl 2013; 14: 237–242.CrossRefPubMed Pirillo A, Catapano AL. Omega-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia. Atheroscler Suppl 2013; 14: 237–242.CrossRefPubMed
36.
go back to reference Kim M, Nam JH, Oh DH, Park Y. Erythrocyte α-linolenic acid is associated with the risk for mild dementia in Korean elderly. Nutr Res 2010; 30: 756–761.CrossRefPubMed Kim M, Nam JH, Oh DH, Park Y. Erythrocyte α-linolenic acid is associated with the risk for mild dementia in Korean elderly. Nutr Res 2010; 30: 756–761.CrossRefPubMed
37.
go back to reference Laurin D, Verreault R, Lindsay J, Dewailly E, Holub BJ. Omega-3 fatty acids and risk of cognitive impairment and dementia. J Alzheimers Dis 2003; 5: 315–322.PubMed Laurin D, Verreault R, Lindsay J, Dewailly E, Holub BJ. Omega-3 fatty acids and risk of cognitive impairment and dementia. J Alzheimers Dis 2003; 5: 315–322.PubMed
38.
go back to reference Bora E, Harrison BJ, Yücel M, Pantelis C. Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol Med 2013; 43: 2017–2026.CrossRefPubMed Bora E, Harrison BJ, Yücel M, Pantelis C. Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol Med 2013; 43: 2017–2026.CrossRefPubMed
39.
go back to reference McIntyre RS, Cha DS, Soczynska JK, Woldeyohannes HO, Gallaugher LA, Kudlow P et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety 2013; 30: 515–527.CrossRefPubMed McIntyre RS, Cha DS, Soczynska JK, Woldeyohannes HO, Gallaugher LA, Kudlow P et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety 2013; 30: 515–527.CrossRefPubMed
40.
go back to reference Bountziouka V, Polychronopoulos E, Zeimbekis A, Papavenetiou E, Ladoukaki E, Papairakleous N et al. Long-term fish intake is associated with less severe depressive symptoms among elderly men and women: the MEDIS (MEDiterranean ISlands Elderly) epidemiological study. J Aging Health 2009; 21: 864–880.CrossRefPubMed Bountziouka V, Polychronopoulos E, Zeimbekis A, Papavenetiou E, Ladoukaki E, Papairakleous N et al. Long-term fish intake is associated with less severe depressive symptoms among elderly men and women: the MEDIS (MEDiterranean ISlands Elderly) epidemiological study. J Aging Health 2009; 21: 864–880.CrossRefPubMed
41.
go back to reference Murakami K, Miyake Y, Sasaki S, Tanaka K, Arakawa M. Fish and n-3 polyunsaturated fatty acid intake and depressive symptoms: Ryukyus Child Health Study. Pediatrics 2010; 126: e623–30.CrossRef Murakami K, Miyake Y, Sasaki S, Tanaka K, Arakawa M. Fish and n-3 polyunsaturated fatty acid intake and depressive symptoms: Ryukyus Child Health Study. Pediatrics 2010; 126: e623–30.CrossRef
42.
go back to reference Pottala JV, Talley JA, Churchill SW, Lynch DA, von Schacky C, Harris WS. Red blood cell fatty acids are associated with depression in a case-control study of adolescents. Prostaglandins Leukot Essent Fatty Acids 2012; 86: 161–165.CrossRefPubMed Pottala JV, Talley JA, Churchill SW, Lynch DA, von Schacky C, Harris WS. Red blood cell fatty acids are associated with depression in a case-control study of adolescents. Prostaglandins Leukot Essent Fatty Acids 2012; 86: 161–165.CrossRefPubMed
43.
go back to reference Witte AV, Kerti L, Hermannstädter HM, Fiebach JB, Schreiber SJ, Schuchardt JP et al. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex 2014; 24: 3059–3068.CrossRefPubMed Witte AV, Kerti L, Hermannstädter HM, Fiebach JB, Schreiber SJ, Schuchardt JP et al. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex 2014; 24: 3059–3068.CrossRefPubMed
44.
go back to reference Schacky C von. Omega-3 index and cardiovascular health. Nutrients 2014; 6: 799–814.CrossRef Schacky C von. Omega-3 index and cardiovascular health. Nutrients 2014; 6: 799–814.CrossRef
45.
go back to reference Baghai TC, Varallo-Bedarida G, Born C, Häfner S, Schüle C, Eser D et al. Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 Index. J Clin Psychiatry 2011; 72: 1242–1247.CrossRefPubMed Baghai TC, Varallo-Bedarida G, Born C, Häfner S, Schüle C, Eser D et al. Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 Index. J Clin Psychiatry 2011; 72: 1242–1247.CrossRefPubMed
46.
go back to reference Johnston DT, Deuster PA, Harris WS, Macrae H, Dretsch MN. Red blood cell omega-3 fatty acid levels and neurocognitive performance in deployed U.S. Servicemembers. Nutr Neurosci 2013; 16: 30–38.CrossRefPubMed Johnston DT, Deuster PA, Harris WS, Macrae H, Dretsch MN. Red blood cell omega-3 fatty acid levels and neurocognitive performance in deployed U.S. Servicemembers. Nutr Neurosci 2013; 16: 30–38.CrossRefPubMed
Metadata
Title
Genetic variants of the FADS gene cluster are associated with erythrocyte membrane LC PUFA levels in patients with mild cognitive impairment
Authors
Jan Philipp Schuchardt
T. Köbe
V. Witte
J. Willers
A. Gingrich
V. Tesky
J. Pantel
D. Rujescu
T. Illig
A. Flöel
A. Hahn
Publication date
01-06-2016
Publisher
Springer Paris
Published in
The journal of nutrition, health & aging / Issue 6/2016
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-016-0720-3

Other articles of this Issue 6/2016

The journal of nutrition, health & aging 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine